Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP7 | P09237 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.31 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18126379 | 0.91 | FAAH (0.39) | CA1CA2FAAHNPC1S1PR2 | |
| SCHEMBL18126397 | 0.89 | FAAH (0.42) | CA1CA2FAAH | |
| SCHEMBL18126340 | 0.89 | FAAH (0.42) | CA1CA2FAAH | |
| Acetic Acid SCHEMBL21681579 | 0.87 | FFAR3 (0.35) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL6005443 | 0.85 | USP2 (0.33) | MMP9ALDH1A1LMNATSHR | |
| Propionic Acid SCHEMBL21681580 | 0.84 | FFAR3 (0.48) | ALDH1A1POLBHSD17B10MEN1TSHR | |
| SCHEMBL15868137 | 0.83 | CA2 (0.32) | CA2MEN1TSHRKMT2A | |
| SCHEMBL2384895 | 0.81 | HPGD (0.44) | CA1CA2FAAHNPC1S1PR2 | |
| SCHEMBL4318769 | 0.80 | CA1 (0.33) | CA1CA2FAAHMMP2MMP7 | |
| SCHEMBL1341402 | 0.79 | FAAH (0.50) | CA1CA2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116942890-A | Antibacterial anti-inflammatory thermosensitive hydrogel with function of promoting wound closure and preparation method thereof | 西南交通大学 | 2023-10-27 | — | — | CN | claimed |
| EP-3190139-B1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | IND TECH RES INST (TW) | 2019-08-28 | — | — | EP | claimed |
| US-20170197914-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-07-13 | — | — | US | claimed |
| EP-3190139-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | Industrial Technology Research Institute (TW) | 2017-07-12 | — | — | EP | claimed |
| US-6313321-B1 | Process for preparing β-hydroxy-γ-butyrolactones and β-(meth)acryloyloxy-γ-butrolactones | MITSUBISHI RAYON CO., LTD. (JP) | 2001-11-06 | — | — | US | claimed |
| JP-9157284-A | — | — | None | — | — | JP | disclosed |
| CN-110870112-B | Lithium ion secondary battery | 日本电气株式会社 | 2024-09-20 | — | — | CN | disclosed |
| US-20240297344-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| CN-114174257-B | Process for preparing alkanesulphonic acids | 巴斯夫欧洲公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-116942890-B | Antibacterial anti-inflammatory thermosensitive hydrogel with function of promoting wound closure and preparation method thereof | 西南交通大学 | 2024-04-02 | — | — | CN | disclosed |
| US-11817546-B2 | Lithium ion secondary battery | NEC CORPORATION (JP) | 2023-11-14 | — | — | US | disclosed |
| CN-116942890-A | Antibacterial anti-inflammatory thermosensitive hydrogel with function of promoting wound closure and preparation method thereof | 西南交通大学 | 2023-10-27 | — | — | CN | disclosed |
| EP-1052258-A1 | PROCESS FOR PRODUCING BETA-HYDROXY-GAMMA-BUTYROLACTONE DERIVATIVES AND BETA-(METH)ACRYLOYLOXY-GAMMA-BUTYROLACTONE DERIVATIVES | Mitsubishi Rayon Co., Ltd. (JP) | 2000-11-15 | — | — | EP | disclosed |
| EP-1036794-A1 | 2-ARYL-8-OXODIHYDROPURINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME, AND INTERMEDIATES THEREOF | Dainippon Pharmaceutical Co., Ltd. (JP) | 2000-09-20 | — | — | EP | disclosed |
| US-5972946-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| US-5786355-A | COMPOUNDS FOR TREATMENT OF CANCER, RHEUMATISM, DIABETIC RETINOPATHY OR PSORIASIS | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1998-07-28 | — | — | US | disclosed |
| EP-0826673-A1 | ACETAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1998-03-04 | — | — | EP | disclosed |
| JP-H09157284-A | PRODUCTION OF GLUCOPYRANOSE DERIVATIVE | ONO PHARMACEUT CO LTD | 1997-06-17 | — | — | JP | disclosed |
| EP-0767170-A1 | NOVEL 4,6-DIARYLPYRIMIDINE DERIVATIVES AND SALTS THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1997-04-09 | — | — | EP | disclosed |
| US-4940090-A | ACRYLAMIDO-OR SULFONATED VINYL ETHER COMONOMER, ENHANCED OIL RECOVERY | MOBIL OIL CORPORATION (US) | 1990-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197914-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | C1S, ARSA, TST | CA1 1781/4885CA2 611/4885FAAH 1521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.